WallStSmart

Linde plc Ordinary Shares (LIN)vsLyondellBasell Industries NV (LYB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Linde plc Ordinary Shares generates 14% more annual revenue ($35.45B vs $31.19B). LIN leads profitability with a 20.4% profit margin vs -1.1%. LYB appears more attractively valued with a PEG of 1.53. LYB earns a higher WallStSmart Score of 65/100 (C+).

LIN

Buy

64

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 4.0Quality: 4.0
Piotroski: 3/9Altman Z: 1.49

LYB

Buy

65

out of 100

Grade: C+

Growth: 6.7Profit: 4.5Value: 4.3Quality: 5.0
Piotroski: 2/9Altman Z: 1.57
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LINSignificantly Overvalued (-50.9%)

Margin of Safety

-50.9%

Fair Value

$308.97

Current Price

$464.41

$155.44 premium

UndervaluedFair: $308.97Overvalued
LYBOvervalued (-7.3%)

Margin of Safety

-7.3%

Fair Value

$55.45

Current Price

$63.69

$8.24 premium

UndervaluedFair: $55.45Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LIN3 strengths · Avg: 9.0/10
Market CapQuality
$214.92B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
20.4%9/10

Keeps 20 of every $100 in revenue as profit

Operating MarginProfitability
28.1%8/10

Strong operational efficiency at 28.1%

LYB3 strengths · Avg: 8.7/10
EPS GrowthGrowth
396.0%10/10

Earnings expanding 396.0% YoY

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
19.8%8/10

19.8% revenue growth

Areas to Watch

LIN4 concerns · Avg: 3.3/10
PEG RatioValuation
1.794/10

Expensive relative to growth rate

P/E RatioValuation
29.8x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.492/10

Distress zone — elevated risk

LYB4 concerns · Avg: 3.5/10
PEG RatioValuation
1.534/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.574/10

Distress zone — elevated risk

Debt/EquityHealth
1.333/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : LIN

The strongest argument for LIN centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 20.4% and operating margin at 28.1%.

Bull Case : LYB

The strongest argument for LYB centers on EPS Growth, Price/Book, Revenue Growth. Revenue growth of 19.8% demonstrates continued momentum.

Bear Case : LIN

The primary concerns for LIN are PEG Ratio, P/E Ratio, Piotroski F-Score.

Bear Case : LYB

The primary concerns for LYB are PEG Ratio, Altman Z-Score, Debt/Equity.

Key Dynamics to Monitor

LIN profiles as a mature stock while LYB is a growth play — different risk/reward profiles.

LIN carries more volatility with a beta of 0.73 — expect wider price swings.

LYB is growing revenue faster at 19.8% — sustainability is the question.

LIN generates stronger free cash flow (833M), providing more financial flexibility.

Bottom Line

LYB scores higher overall (65/100 vs 64/100) and 19.8% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Linde plc Ordinary Shares

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Linde plc is a multinational chemical company. It is the largest industrial gas company by market share and revenue. It serves customers in the healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, electronics and water treatment industries. The company's primary business is the manufacturing and distribution of atmospheric gases, including oxygen, nitrogen, argon, rare gases, and process gases, including carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.

Visit Website →

LyondellBasell Industries NV

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

LyondellBasell Industries N.V. (NYSE: LYB) is a Dutch-domiciled multinational chemical company with American and British roots, incorporated in the Netherlands, with U.S. operations headquarters in Houston, Texas, and offices in London, UK. The company is the largest licensor of polyethylene and polypropylene technologies. It also produces ethylene, propylene, polyolefins, and oxyfuels.

Want to dig deeper into these stocks?